IDNA
iShares Genomics Immunology and Healthcare ETF
1W: -0.3%
1M: +3.6%
3M: +20.1%
YTD: +58.9%
1Y: +72.2%
3Y: +109.2%
5Y: -18.7%
$41.65
+0.01 (+0.02%)
Weekly Expected Move ±3.7%
$39
$40
$42
$43
$45
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Portfolio Health Summary
IS Overall Score
47.6
★★★★★
Altman Z-Score
5.86
Safe
Weight Coverage
98%
of portfolio analyzed
Holdings Matched
45
with fundamental data
InsiderStreet Scorecard
★★★★★
47.6
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
5.86
Safe Zone (>2.99)
Piotroski F-Score
4.2 / 9
Moderate
Beneish M-Score
0.89
Possible Manipulator
Credit Score
—
Earnings Quality
55.5 / 100
Portfolio Valuation
P/E
45.49x
P/B
1.34x
P/S
2.15x
EV/EBITDA
11.19x
EV/Revenue
3.01x
P/FCF
13.66x
P/OCF
10.82x
PEG
4.05x
Earnings Yield
2.20%
FCF Yield
7.32%
OCF Yield
9.24%
Median P/E
-5.72x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+28.0%
Net Income
-4.6%
EPS
-1.0%
FCF
+12.2%
EBITDA
-9.7%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+62.4%
Rev CAGR 5Y
+11.6%
EPS CAGR 3Y
+11.2%
EPS CAGR 5Y
+8.1%
FCF CAGR 3Y
+6.9%
FCF CAGR 5Y
+14.1%
EBITDA CAGR 3Y
+8.2%
EBITDA CAGR 5Y
+10.4%
Payout Ratio
60.62%
Buyback Yield
0.81%
Dividend Yield
0.81%
Total Shareholder Return
-1.59%
Earnings Stability
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$41.65
Median 1Y
$42.77
5th Pctile
$26.21
95th Pctile
$69.87
Ann. Volatility
29.8%
25th–75th percentile
5th–95th percentile
Median path
Historical
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 45.49 |
| Portfolio P/B | 1.34 |
| Portfolio P/S | 2.15 |
| EV/EBITDA | 11.19 |
| EV/Revenue | 3.01 |
| P/FCF | 13.66 |
| P/OCF | 10.82 |
| PEG | 4.05 |
| Earnings Yield | 2.20% |
| FCF Yield | 7.32% |
| OCF Yield | 9.24% |
| Median P/E | -5.72 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 67.20% |
| Operating Margin | 11.16% |
| Net Margin | 4.35% |
| FCF Margin | 15.60% |
| ROE | 2.83% |
| ROA | 1.40% |
| ROIC | 3.07% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 0.63 |
| Debt/Assets | 0.31 |
| Net Debt/EBITDA | 3.22 |
| Interest Coverage | 2.04 |
| Current Ratio | 1.20 |
| Quick Ratio | 0.69 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 27.98% |
| Net Income Growth | -4.60% |
| EPS Growth | -0.97% |
| FCF Growth | 12.18% |
| EBITDA Growth | -9.74% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 62.38% |
| Revenue CAGR 5Y | 11.61% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 11.24% |
| EPS CAGR 5Y | 8.12% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 6.90% |
| FCF CAGR 5Y | 14.10% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 8.24% |
| EBITDA CAGR 5Y | 10.42% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 7.06% |
| Net Income CAGR 5Y | 5.79% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 47.6 |
| IS Profitability | 39.5 |
| IS Balance Sheet | 55.1 |
| IS Earnings Quality | 55.5 |
| IS Growth | 49.9 |
| IS Value | 42.2 |
| IS Momentum | 60.5 |
| IS Safety | 73.1 |
| IS Quality | 57.4 |
| Altman Z-Score | 5.86 |
| Piotroski F-Score | 4.16 |
| Beneish M-Score | 0.89 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 0.81% |
| Payout Ratio | 60.62% |
| Buyback Yield | 0.81% |
| Total Shareholder Return | -1.59% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.650 |
| Earnings Stability | 0.382 |
| Earnings Persistence | 0.734 |
| Margin Stability | 0.616 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | -5.72 |
| Median P/B | 3.72 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 98.42% |
| Holdings Matched | 45 |
| Total Holdings | 47 |